| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2867759 | Angiología | 2011 | 4 Pages |
Abstract
This is the first study to show that treatment with bosentan may be useful in non-revascularisable patients, improving pain and lesion size, with a low incidence of major amputations in the short term.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A. MartÃn Conejero, M. Muela Méndez, S. González Sánchez, I. MartÃnez López, R. Rial Horcajo, F.J. Serrano Hernando,